Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
The Laryngoscope
|
May 9, 2023
Auto-Substitutions to Optimize Perioperative Antimicrobial Prophylaxis: Pre-Post Intervention Study
Suhaima Tunio, Agnieszka Dzioba, Rita Dhami, et al.
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC
|
January 17, 2022
Assessing the impact of a cannabis course on pharmacy students' understanding, beliefs and preparedness regarding medical and recreational cannabis
Vikas Parihar, Michael A Beazely, Laura Katz, et al.
Clinical and Experimental Medicine
|
December 16, 2022
Association of body mass index with COVID-19-related neurologic sequelae: a retrospective cohort study
Sameer Elsayed, Ana Cabrera, Danielle Ouellette, et al.
Journal of Global Antimicrobial Resistance
|
June 22, 2024
Real-life experience with IV dalbavancin in Canada; results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry
George Zhanel, Michael Silverman, Janhavi Malhotra, et al.
Expert Review of Anti-Infective Therapy
|
September 26, 2024
Ceftolozane/Tazobactam treatment for patients with hospital-acquired and ventilatory-associated bacterial pneumonia in Canada in 2022-2024: results from the CLEAR registry
George G Zhanel, Rita Dhami, Melanie Baxter, et al.
Journal of Global Antimicrobial Resistance
|
February 4, 2021
Real-life experience with ceftobiprole in Canada: Results from the CLEAR (CanadianLEadership onAntimicrobialReal-life usage) registry
George G Zhanel, Justin Kosar, Melanie Baxter, et al.
Journal of Global Antimicrobial Resistance
|
April 8, 2023
Real-life experience with IV fosfomycin in Canada: Results from the Canadian LEadership on Antimicrobial Real-life usage (CLEAR) registry
George Zhanel, Melanie Baxter, Maggie Wong, et al.
Journal of Global Antimicrobial Resistance
|
May 13, 2021
Real-life experience with ceftolozane/tazobactam in Canada: results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry
George G Zhanel, Rita Dhami, Melanie Baxter, et al.
Expert Review of Anti-Infective Therapy
|
July 15, 2024
How is ceftobiprole used in Canada: the CLEAR study final results
George G Zhanel, Justin Kosar, Melanie Baxter, et al.
Antimicrobial Resistance and Infection Control
|
April 19, 2023
Antimicrobial use among paediatric inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program, 2017/2018
Wallis Rudnick, John Conly, Daniel J G Thirion, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
The Laryngoscope
|
May 9, 2023
Auto-Substitutions to Optimize Perioperative Antimicrobial Prophylaxis: Pre-Post Intervention Study
Suhaima Tunio, Agnieszka Dzioba, Rita Dhami, et al.
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC
|
January 17, 2022
Assessing the impact of a cannabis course on pharmacy students' understanding, beliefs and preparedness regarding medical and recreational cannabis
Vikas Parihar, Michael A Beazely, Laura Katz, et al.
Clinical and Experimental Medicine
|
December 16, 2022
Association of body mass index with COVID-19-related neurologic sequelae: a retrospective cohort study
Sameer Elsayed, Ana Cabrera, Danielle Ouellette, et al.
Journal of Global Antimicrobial Resistance
|
June 22, 2024
Real-life experience with IV dalbavancin in Canada; results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry
George Zhanel, Michael Silverman, Janhavi Malhotra, et al.
Expert Review of Anti-Infective Therapy
|
September 26, 2024
Ceftolozane/Tazobactam treatment for patients with hospital-acquired and ventilatory-associated bacterial pneumonia in Canada in 2022-2024: results from the CLEAR registry
George G Zhanel, Rita Dhami, Melanie Baxter, et al.
Journal of Global Antimicrobial Resistance
|
February 4, 2021
Real-life experience with ceftobiprole in Canada: Results from the CLEAR (CanadianLEadership onAntimicrobialReal-life usage) registry
George G Zhanel, Justin Kosar, Melanie Baxter, et al.
Journal of Global Antimicrobial Resistance
|
April 8, 2023
Real-life experience with IV fosfomycin in Canada: Results from the Canadian LEadership on Antimicrobial Real-life usage (CLEAR) registry
George Zhanel, Melanie Baxter, Maggie Wong, et al.
Journal of Global Antimicrobial Resistance
|
May 13, 2021
Real-life experience with ceftolozane/tazobactam in Canada: results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry
George G Zhanel, Rita Dhami, Melanie Baxter, et al.
Expert Review of Anti-Infective Therapy
|
July 15, 2024
How is ceftobiprole used in Canada: the CLEAR study final results
George G Zhanel, Justin Kosar, Melanie Baxter, et al.
Antimicrobial Resistance and Infection Control
|
April 19, 2023
Antimicrobial use among paediatric inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program, 2017/2018
Wallis Rudnick, John Conly, Daniel J G Thirion, et al.
Page
of 2